Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Collard

Showing results (221-230 of 250) with videos related to

Pageof 25
Sort By:
Thorax|September 14, 2014
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisDaryle J DePianto, Sanjay Chandriani, Alexander R Abbas, et al.
Respiratory Medicine|July 5, 2015
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosisDeborah Assayag, Eric Vittinghoff, Christopher J Ryerson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2014
Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblastsSanjay Chandriani, Daryle J DePianto, Elsa N N'Diaye, et al.
Chest|November 5, 2017
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIvan O Rosas, Hilary J Goldberg, Harold R Collard, et al.
Respiratory Medicine|May 16, 2017
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseJulie Morisset, Eric Vittinghoff, Bo Young Lee, et al.
Chest|November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung DiseaseAlessia Comes, Alyson W Wong, Jolene H Fisher, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice GuidelineGanesh Raghu, Bram Rochwerg, Yuan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
Scientific Reports|January 23, 2016
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease ProbesNimali P Withana, Xiaowei Ma, Helen M McGuire, et al.
Pageof 25

Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
Thorax|September 14, 2014
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisDaryle J DePianto, Sanjay Chandriani, Alexander R Abbas, et al.
Respiratory Medicine|July 5, 2015
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosisDeborah Assayag, Eric Vittinghoff, Christopher J Ryerson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2014
Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblastsSanjay Chandriani, Daryle J DePianto, Elsa N N'Diaye, et al.
Chest|November 5, 2017
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIvan O Rosas, Hilary J Goldberg, Harold R Collard, et al.
Respiratory Medicine|May 16, 2017
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseJulie Morisset, Eric Vittinghoff, Bo Young Lee, et al.
Chest|November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung DiseaseAlessia Comes, Alyson W Wong, Jolene H Fisher, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice GuidelineGanesh Raghu, Bram Rochwerg, Yuan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
Scientific Reports|January 23, 2016
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease ProbesNimali P Withana, Xiaowei Ma, Helen M McGuire, et al.
Pageof 25